Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes

Conditions

• Type 2 Diabetes

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• The DECIDE Self-Management Program — BEHAVIORAL
  DECIDE is an evidence-based diabetes self-management support program that uses problem-solving skills training to educate and empower individuals in managing their diabetes. For this study, it has been adapted to include education and support around CGM use. The program will be delivered virtually by a trained facilitator over 9 weeks.
• Continuous Glucose Monitoring (CGM) — BEHAVIORAL
  Participants will be provided Freestyle Libre CGM sensors to wear during the intervention and follow-up periods (up to 22 weeks). CGM includes a small sensor attached to the arm that provides real-time glucose data by connecting via Bluetooth to an application on a smartphone. The sensor will be replaced every 2 weeks, and participants will be able to see their glucose values on their personal smartphone device.

Study Details

The purpose of this study is to determine if combining a virtual diabetes self-management program (DECIDE®) with continuous glucose monitoring (CGM) is practical and well-received by adults with type 2 diabetes. Twenty participants will attend the 9-week, virtual DECIDE Self-Management Program. They will receive CGM sensors to wear during the 22-week study to track their blood sugar. Participants will complete questionnaires at three time points -- at baseline, 1 week after the DECIDE Program ends, and 3 months after the DECIDE Program ends. They will also complete a blood draw to measure hemoglobin A1C at baseline and 3 months after the intervention ends. Additionally, they will complete a brief interview after the program ends to gather insights into participants' experiences with the program. The study aims to examine whether this integrated approach will be both feasible and acceptable, potentially leading to better diabetes management and improved health outcomes.

Key Dates

First listed

Aug 3, 2026

Start date

Aug 1, 2026

Status verified

Jul 2026

Primary completion

Dec 31, 2026

Completion

Dec 31, 2026

Study Design

Enrollment

20 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Experimental: DECIDE Self-Management Program + CGM
  Participants will receive: 1. The 9-week, virtually delivered DECIDE Self-Management Program. 2. Continuous glucose monitoring (CGM) sensors

Primary Outcome Measure

Feasibility of the intervention [ Time Frame: These outcomes will be monitored continuously throughout study completion, approximately 6 months ]

Central Contacts

• Elizabeth A Vrany
  516-600-1483
  [email protected]

Locations (1)

Find similar trials in Manhasset, NY

Related Studies

• Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
  Recruiting · NYU Langone Health · New York, New York
• Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
  Recruiting · NYU Langone Health · New York, New York
• LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
  Recruiting · NYU Langone Health · New York, New York
• High Fructose Diet, the Gut Microbiome, and Metabolic Health
  Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York